Home

DexCom, Inc. - Common Stock (DXCM)

59.08
-9.12 (-13.37%)
NASDAQ · Last Trade: Oct 31st, 3:29 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Why DexCom (DXCM) Stock Is Falling Today
Shares of medical device company DexCom (NASDAQ:DXCM) fell 14.8% in the afternoon session after the company reported underwhelming earnings. 
Via StockStory · October 31, 2025
Discover which S&P500 stocks are making waves on Friday.chartmill.com
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · October 31, 2025
Why DexCom Stock Is Crashing Todayfool.com
The diabetes equipment provider had a strong quarter, but next year is looking weaker than expected.
Via The Motley Fool · October 31, 2025
Gapping S&P500 stocks in Friday's sessionchartmill.com
Friday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Via Chartmill · October 31, 2025
Dexcom Stock Plunges 13% After-Hours As Q3 Margin Pressures Eclipse Record Profit — Retail Sees ‘Buy The Dip’ Setupdexcom
Via Stocktwits · October 30, 2025
Earnings Scheduled For October 30, 2025benzinga.com
Via Benzinga · October 30, 2025
An Overview of DexCom's Earningsbenzinga.com
Via Benzinga · October 29, 2025
Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday?benzinga.com
Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive.
Via Benzinga · October 31, 2025
DXCM Q3 Deep Dive: Margin Pressures Offset Strong Diabetes Access and Product Expansion
Medical device company DexCom (NASDAQ:DXCM) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 21.6% year on year to $1.21 billion. The company expects the full year’s revenue to be around $4.64 billion, close to analysts’ estimates. Its non-GAAP profit of $0.61 per share was 7.5% above analysts’ consensus estimates.
Via StockStory · October 31, 2025
Top S&P500 movers in Friday's pre-market sessionchartmill.com
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
Via Chartmill · October 31, 2025
Dexcom Stock, Down 13%, Haunted By Its 'Surprisingly Cautious' Outlookdexcom
Dexcom's solid third-quarter report was overshadowed Friday by its "surprisingly cautious" outlook, and Dexcom stock tumbled.
Via Investor's Business Daily · October 31, 2025
Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · October 31, 2025
These S&P500 stocks are moving in today's after hours sessionchartmill.com
As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.
Via Chartmill · October 30, 2025
DexCom Inc (NASDAQ:DXCM) Reports Q3 2025 Earnings Beat Amid Stock Plunge on Guidance Concernschartmill.com
DexCom Q3 2025 earnings beat estimates, but stock fell due to full-year revenue guidance that missed analyst expectations.
Via Chartmill · October 30, 2025
DexCom (NASDAQ:DXCM) Beats Q3 Sales Expectations But Stock Drops
Medical device company DexCom (NASDAQ:DXCM) announced better-than-expected revenue in Q3 CY2025, with sales up 21.6% year on year to $1.21 billion. The company expects the full year’s revenue to be around $4.64 billion, close to analysts’ estimates. Its non-GAAP profit of $0.61 per share was 7.5% above analysts’ consensus estimates.
Via StockStory · October 30, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · October 30, 2025
What Does the Market Think About DexCom Inc?benzinga.com
Via Benzinga · October 30, 2025
Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday?benzinga.com
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome Powell th
Via Benzinga · October 30, 2025
Should You Buy DexCom Stock Before Oct. 31?fool.com
The company hasn't had a great year. Is it about to turn things around?
Via The Motley Fool · October 30, 2025
DexCom (DXCM) Reports Earnings Tomorrow: What To Expect
Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Thursday after market close. Here’s what you need to know.
Via StockStory · October 28, 2025
DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitordexcom
Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify.
Via Benzinga · October 28, 2025
Dexcom Shares Slide After Short Seller Flags 3 Additional Deaths From G7 Devicesdexcom
Short seller Hunterbrook stated that at least 13 G7 users have died since the device launched in 2023.
Via Stocktwits · October 28, 2025
Forecasting The Future: 13 Analyst Projections For DexCombenzinga.com
Via Benzinga · October 21, 2025
2 Stocks Down 17% and 21% to Buy Right Nowfool.com
Both companies have faced recent challenges, but look likely to overcome them.
Via The Motley Fool · October 14, 2025
Q2 Earnings Roundup: DexCom (NASDAQ:DXCM) And The Rest Of The Patient Monitoring Segment
Let’s dig into the relative performance of DexCom (NASDAQ:DXCM) and its peers as we unravel the now-completed Q2 patient monitoring earnings season.
Via StockStory · October 13, 2025